RA disease impact in patients not treated with advanced therapies; survey findings from the National Rheumatoid Arthritis Society
by NRAS
Recently NICE published a Final Appraisal Document in respect of a new JAK inhibitor (filgotinib – Jyseleca) giving access to people with RA who have so called ‘moderate’ disease in addition to those with ‘severe’ disease. This is the first time NICE have broadened their eligibility criteria for access to advanced therapies and is warmly welcomed by NRAS. This comes at the same time as a paper published by the National Rheumatoid Arthritis Society (P.…
Read more of this article
At the first meeting in June, they decided to name themselves the “Young Voices” to reflect their role in raising awareness of the issues affecting young people living with these chronic conditions. … 
NRAS is very excited to announce their brand new website has gone live. A lot of work has gone into development, implementation and design, ensuring an improvement in how NRAS provides information to their members, supporters and the wider rheumatoid arthritis (RA) community.
The Faculty of Sport and Exercise Medicine (UK) has published a statement on the role SEM consultants can play in new NHS long Covid rehabilitation clinics being set up in England.
The National Orthopaedic Alliance (NOA) is moving forward with plans to create an Orthopaedic Quality Improvement (inc. Clinical Audit) Network. The new network will enable specialist orthopaedic centres to be connected as a primary source of support and expertise in all aspects of quality improvement and clinical audit for orthopaedics. It is being led and coordinated by the NOA as part of its remit to bring together orthopaedic centres around the UK to share best practice and address shared challenges.
The report makes recommendations including a tailored exercise programme and broad interventions to support increased activity levels; optimising nutrition and embedding behaviour change.